Analysis Of Income And Expense [Abstract]

BioGaia - Filing #702781

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	—	—	—	—	—	—	785 110 SEK	—	747 077 SEK	—	—	—	—	—
Material income and expense [abstract]
Research and development expense	—	—	—	—	—	—	—	105 467 SEK	—	104 663 SEK	—	—	—	—	—
Finance income (cost)	—	—	—	—	—	—	—	1 025 SEK	—	567,000 SEK	—	—	—	—	—
Sales and marketing expense	—	—	—	—	—	—	—	192 437 SEK	—	171 634 SEK	—	—	—	—	—
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	—	—	—	1 994 SEK	1 994 SEK	—	1 994 SEK	—	4 059 SEK	4 059 SEK	—	—	4 059 SEK	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	0 SEK	0 SEK	196 273 SEK	0 SEK	1 994 SEK	198 267 SEK	0 SEK	198 267 SEK	0 SEK	175 671 SEK	4 059 SEK	0 SEK	179 730 SEK	175 671 SEK	0 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	—	—	—	—	—	—	198 267 SEK	—	175 671 SEK	—	—	—	—	—
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	—	—	—	—	—	—	—	– SEK	—	– SEK	—	—	—	—	—